0001192482-13-000214.txt : 20131211 0001192482-13-000214.hdr.sgml : 20131211 20131211180756 ACCESSION NUMBER: 0001192482-13-000214 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131211 FILED AS OF DATE: 20131211 DATE AS OF CHANGE: 20131211 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TETRALOGIC PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001361248 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 343 PHOENIXVILLE PIKE CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-889-9900 MAIL ADDRESS: STREET 1: 343 PHOENIXVILLE PIKE CITY: MALVERN STATE: PA ZIP: 19355 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gavin Brenda D CENTRAL INDEX KEY: 0001488182 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36208 FILM NUMBER: 131271962 MAIL ADDRESS: STREET 1: C/O QUAKER BIOVENTURES STREET 2: CIRCA CENTRE, 2929 ARCH STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 3 1 edgar.xml PRIMARY DOCUMENT X0206 3 2013-12-11 0 0001361248 TETRALOGIC PHARMACEUTICALS CORP TLOG 0001488182 Gavin Brenda D C/O TETRALOGIC PHARMACEUTICALS CORP 343 PHOENIXVILLE PIKE MALVERN PA 19355 1 0 0 0 Common Stock 449322 I By: Quaker BioVentures, L.P. Common Stock 275245 I By: Quaker BioVentures Tobacco Fund, L.P. Common Stock 175518 I By: BioAdvance Ventures, L.P. Common Stock Warrants .85 Common Stock 2553 I By: Quaker BioVentures, L.P. Common Stock Warrants .85 Common Stock 3404 I By: Quaker BioVentures Tobacco Fund, L.P. Common Stock Warrants .85 Common Stock 1779 I By: BioAdvance Ventures, L.P. Common Stock Warrants .85 Common Stock 3063 I By: Quaker BioVentures, L.P. Common Stock Warrants .85 Common Stock 4084 I By: Quaker BioVentures Tobacco Fund, L.P. Common Stock Warrants .85 Common Stock 2135 I By: BioAdvance Ventures, L.P. Convertible Notes Common Stock I By: Quaker BioVentures, L.P. Convertible Notes Common Stock I By: Quaker BioVentures Tobacco Fund, L.P. Convertible Notes Common Stock I By: BioAdvance Ventures, L.P. Series C Warrants 6.4022 Common Stock I By: Quaker BioVentures, L.P. Series C Warrants 6.4022 Common Stock I By: Quaker BioVentures Tobacco Fund, L.P. Series C Warrants 6.4022 Common Stock I By: BioAdvance Ventures, L.P. The warrants are immediately exercisable. The warrants expire on the later of 11/25/2019 or five years after the consummation of the Company's initial public offering. The warrants are immediately exercisable. The warrants expire on the later of 03/10/2020 or five years after the consummation of the Company's initial public offering. The Convertible Notes will be automatically converted into Common Stock without payment of further consideration upon the closing of the Issuer's initial public offering and have no expiration date. Warrants will be automatically exercised immediately prior to the closing of the Issuer's initial public offering. Warrants are exercisable for a number of shares of common stock equal to the warrant amount divided by the exercise price and will be net exercised at the initial public offering price. These securities are owned of record by Quaker BioVentures, L.P., Quaker BioVentures Tobacco Fund, L.P. and BioAdvance Ventures, L.P. Brenda D. Gavin disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein. /s/ Richard L. Sherman, Attorney-In-Fact for Brenda Gavin 2013-12-11